Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

Inspiring Stories of Patients Living with ASMD

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?